Clinical Laserthermia Systems AB publishes Year-end report January – December 2022
Summary of the year-end report (relates to the Group) Twelve months (01/01/2022–12/31/2022) · Net sales totaled SEK 6,268,000 (SEK 2 245,000). · Profit/loss after financial items totaled SEK -71,265,000 (SEK -64,141,000). · Basic and diluted earnings per share totaled SEK -0.85 (SEK -1.12). · The equity ratio at December 31, 2022, was 18,6% (31,7%). Fourth quarter (10/01/2022–12/31/2022) · Net sales totaled SEK 4,295,000 (SEK 1,344,000). · Profit/loss after financial items amounted to SEK -19,618,000 (SEK -19,584,000). · Basic and diluted earnings per